Contribute Try STAT+ Today

Nearly a year has gone by since several Chilean lawmakers asked the government to make it possible to issue compulsory licenses for prescription drugs, but no action was taken. Now, more than two dozen advocacy groups from around the world are pressing the health ministry to proceed.

Last January, the lower house of the Chilean congress passedresolution instructing the government to make it possible to issue compulsory licenses for prescription drugs. A few weeks later, several lawmakers asked Chilean health minister Carmen Castillo Taucher to issue compulsory licenses for the Xtandi prostate cancer therapy and several hepatitis C medicines sold by Gilead Sciences (GILD).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.